Structurally, anthocyanins belong to the flavonoid family and are characterised by a flavylium cation (2-phenylchromenylium) core. They occur in plant tissue predominantly as glycosides , bound to one or more sugar molecules , which stabilises the pigment and influences its solubility. The specific colour expressed depends on pH, co-pigmentation, and the number and position of hydroxyl and methoxyl substituents on the B-ring of the core structure.
Common dietary sources include blueberries, blackcurrants, red cabbage, purple corn, elderberries, and red-skinned grapes. Concentrations vary considerably by cultivar, growing conditions, and post-harvest handling. In plants, anthocyanins are understood to serve roles in pollinator attraction, photoprotection against UV radiation, and defence signalling against herbivores and pathogens.
In phytochemical research, anthocyanins are studied for their antioxidant activity in vitro , their capacity to donate electrons and quench free radicals under laboratory conditions. Researchers and regulatory bodies note that antioxidant activity measured in cell-free assays does not directly predict biological effects in living systems; bioavailability after oral ingestion is relatively low and metabolite profiles are complex. The evidence base in humans remains an active area of investigation, and no established therapeutic claims are recognised by the Therapeutic Goods Administration (TGA) for isolated anthocyanin preparations in Australia.
In Australia, products containing anthocyanins may be listed or registered on the Australian Register of Therapeutic Goods (ARTG) if they meet the relevant evidentiary and manufacturing standards under the Therapeutic Goods Act 1989. Permitted health claims for listed medicines are confined to the TGA's pre-approved indications list; unapproved claims constitute a regulatory offence.
Sources: